Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CTMX
CTMX logo

CTMX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

CTMX News

CytomX Therapeutics Price Target Raised by Analysts

Mar 18 2026stocktwits

CytomX Therapeutics Prices Public Offering

Mar 18 2026Yahoo Finance

CytomX Launches $250 Million Public Offering

Mar 18 2026seekingalpha

CytomX Announces Pricing of Public Offering

Mar 18 2026NASDAQ.COM

CytomX Launches $250 Million Public Offering

Mar 17 2026NASDAQ.COM

CytomX Launches $250 Million Stock Offering to Fund Cancer Drug Development

Mar 17 2026stocktwits

CytomX Therapeutics Stock Surges 44.23% Following Positive Phase 1 Data

Mar 16 2026Fool

CytomX Therapeutics Stock Soars 44.23% After Positive Phase 1 Data

Mar 16 2026NASDAQ.COM

CTMX Events

No data

No data

CTMX Monitor News

CytomX launches $250 million public offering amid financial challenges

Mar 18 2026

CytomX Reports Disappointing FY Results Amid Revenue Decline

Mar 16 2026

CTMX Earnings Analysis

No Data

No Data

People Also Watch